Helius Med Technolog (HSDT) 2.3494 $HSDT
Helius Medical Technologies, Inc. to Present at Euro Pacific Capital's 4th Annual Global Investment Conference
ACCESSWIRE - Thu Sep 04, 11:44AM CDT
NEWTOWN, PENNSYLVANIA AND VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / September 4, 2014 / Helius Medical Technologies, Inc. (CSE: HSM) ("Helius" or the "Company"

is pleased to announce its participation in the upcoming Global Investment Conference sponsored by Peter Schiff's Euro Pacific Capital on Tuesday, September 9th, 2014.
Helius Medical Technologies, Inc. Announces Consulting Agreement and Grant of Options
ACCESSWIRE - Mon Jul 14, 8:58PM CDT
NEWTOWN, PENNSYLVANIA AND VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / July 14, 2014 / Helius Medical Technologies, Inc. (CSE: HSM) ("Helius" or the "Company"

is pleased to announce that it has retained Brian Bapty, Ph.D., as a consultant. Dr. Bapty received his Ph.D. in Experimental Medicine and his B.Sc. in Cell and Developmental Biology from the University of British Columbia. His extensive experience in capital markets and prior work with institutional investors will be invaluable as the Company continues to attract investor interest and build shareholder value with the development of its patent pending technology that is believed will enable the first non-invasive means for delivering neurostimulation through the oral cavity (the "PoNSTM"

.